NCBI PubMed Central
open access
Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effects of pyrazinamide and/or ethambutol resistance on Tuberculosis treatment outcome by whole genome sequencing, South Africa 2020 – 2022#447668
- DYNAMIC MODELLING OF NEXT GENERATION SEQUENCING (NGS) AS A DIAGNOSTIC TOOL FOR DRUG-RESISTANT TUBERCULOSIS IN HIGH-BURDEN SETTINGS: A COST EFFECTIVENESS ANALYSIS#421310
- Analysis of the cross-study replicability of tuberculosis gene signatures using 49 curated human transcriptomic datasets.#327022
- Test to Treat TB: Impact of Sputum Sequencing-guided Individualised Therapy on Outcomes in Drug-resistant Tuberculosis#896069
- Investigating gains in TB detection during rollout of Genexpert MTB/Rif universal access to drug susceptibility testing algorithm in Manicaland, Zimbabwe, 2017-2018#267524
Record · ID 338520
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive